Exogenously administered growth hormone and insulin-like growth factor- I alter intracellular Ca2+ handling and enhance cardiac performance: In vitro evaluation in the isolated isovolumic buffer-perfused rat heart

Circulation Research

Volumn 79, Issue 2, 1996, Pages 227-236

  Strömer, Hinrik ^b   Cittadini, Antonio ^b   Douglas, Pamela S ^b   Morgan, James P ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b NONE

Author keywords

Ca2+; insulin like growth factor I; isolated heart; myocardial contractility; somatotropin

Indexed keywords

RECOMBINANT GROWTH HORMONE; RECOMBINANT SOMATOMEDIN C;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CALCIUM TRANSPORT; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; GROWTH REGULATION; HEART PERFORMANCE; HEART PERFUSION; HEART WEIGHT; HISTOPATHOLOGY; HORMONAL REGULATION; NONHUMAN; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; SYSTOLIC BLOOD PRESSURE;

EID: 0030017143     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.79.2.227     Document Type: Article

References (35)

1. Cittadini A, Cuocolo A, Merola B, Fazio S, Sabatini D, Nicolai E, Colao A, Longobardi S, Lombardi G, Saccà L. Impaired cardiac performance in GH-deficient adults and its improvement after GH replacement. Am J Physiol. 1994;267:E219-E225.
2. Merola B, Cittadini A, Longobardi S, Fazio S, Sabatini D, Saccà L, Lombardi G. Cardiac structural and functional abnormalities in adult patients with growth hormone deficiency. J Clin Endocrinol Metab. 1993;77:1671-1676.
3. Mayoux E, Ventura-Clapier R, Timsit J, Béhar-Cohen F, Hoffmann C, Mercadier J-J. Mechanical properties of rat cardiac skinned fibers are altered by chronic growth hormone hypersecretion. Circ Res. 1993;72:57-64.
4. Penney DG, Dunbar JC Jr, Baylerian MS. Cardiomegaly and haemodynamics in rats with a transplantable growth hormone-secreting tumor. Cardiovasc Res. 1985;19:270-277.
5. Timsit J, Riou B, Bertherat J, Wisnewsky C, Kato NS, Weisberg AS, Lubetzki J, Lecarpentier Y, Winegrad S, Mercadier J-J. Effects of chronic growth hormone hypersecretion on intrinsic contractility, energetics, isomyosin pattern and myosin adenosine triphosphatase activity of rat left ventricle. J Clin Invest. 1990;86:507-515.
6. Yang R, Bunting S, Gillett N, Clark R, Hongkui J. Growth hormone improves cardiac performance in experimental heart failure. Circulation. 1995;92:262-267.
7. + current in ventricular myocytes from acromegalic rats. Am J Physiol. 1991;260: H935-H942.
8. Rubin SA, Buttrick P, Malhotra A, Melmed S, Fishbein MC. Cardiac physiology, biochemistry and morphology in response to excess growth hormone in the rat. J Mol Cell Cardiol. 1990;22:429-438.
9. Karmazyn M, Daly MJ, Moffat MP, Dhalla NS. A possible mechanism of inotropic action of prolactin on rat heart. Am J Physiol. 1982;243:E458-E463.
10. Cittadini A, Strömer H, Katz SE, Clark R, Moses AC, Morgan JP, Douglas PS. Differential cardiac effects of growth hormone and IGFI in the rat: a combined in vivo and in vitro evaluation. Circulation. 1996;93:800-809.
11. Kihara Y, Grossman W, Morgan JP. Direct measurement of changes in intracellular calcium transients during hypoxia, ischemia, and reperfusion of the intact mammalian heart. Circ Res. 1989;65:1029-1044.
12. 2+ modulation during postischemic reperfusion in rat heart. Am J Physiol. 1995;268:H100-H111.
13. Apstein CS, Deckelbaum L, Mueller M, Hagopian L, Hood WB. Graded global ischemia and reperfusion: cardiac function and lactate metabolism. Circulation. 1977;55:864-872.
14. 2+ measurements. In: Fozzard HA, Haber E, Jennings RB, Katz AM, Morgan HE, eds. The Heart and Cardiovascular System. New York, NY: Raven Press Publishers; 1986; 1:671-701.
15. Strömer H, Szymanska G, Cittadini A, Morgan JP. A new approach for comparing cardiac parameters in isovolumic langendorff perfused rat hearts of different size. J Invest Med. 1995;43:77a, Abstract.
16. Brooks WW, Healey NA, Sen S, Conrad CH, Bing OHL. Oxygen cost of stress development in hypertrophied and failing hearts from the spontaneously hypertensive rat. Hypertension. 1993;2:56-64.
17. Eberli FR, Apstein CS, Ngoy S, Lorell BH. Exacerbation of left ventricular ischemic diastolic dysfunction by pressure-overload hypertrophy: modification by specific inhibition of cardiac angiotensin converting enzyme. Circ Res. 1992;70:931-943.
18. Allen DG, Blinks JR. Calcium transients in aequorin injected frog cardiac muscle. Nature. 1978;273:509-513.
19. 2+ concentration in living cells. Prog Biophys Mol Biol. 1982;40:1-114.
20. Mirsky I. Elastic properties of the myocardium: a quantitative approach with physiological and clinical applications. In: Berne RM, Sperelakis N, Geiger SR, eds. Handbook of Physiology, Section 2: The Cardiovascular System, Volume I, The Heart, Baltimore, Md; Williams & Wilkins Co; 1979:497-531.
21. Albini CH, Sotos J, Sherman B, Johanson A, Celniker A, Hopwood N, Quattrin T, Mills BJ, MacGillivray M. Diagnostic significance of urinary growth hormone measurements in children with growth failure: correlation between serum and urine growth hormone. Pediatr Res. 1991;29:619-622.
22. Lieberman SA, Bukar J, Chen SA, Celniker AC, Compton PG, Cook J, Albu J, Perlman AJ, Hoffman AR. Effects of recombinant human insulin-like growth factor-1 (rhIGF-1) on total free IGF-I concentrations: IGF-binding proteins and glycemic response in humans. J Endocrinol Metab. 1992;75:30-36.
23. Persson P, Gagnemo-Persson R, Håkanson R. The effect of high or low dietary calcium on bone and calcium homeostasis in young male rats. Calcif Tissue Int. 1993;52:460-464.
24. Grossman W, Carabello BA, Gunther S, Fifer MA. Ventricular wall stress and the development of cardiac hypertrophy and failure. In: Katz AM, Alpert NR, eds. Perspectives in Cardiovascular Research: Myocardial Hypertrophy and Failure. New York, NY: Raven Press Publishers; 1983;7:1-18.
25. Feldman AM, Weinberg EO, Ray PE, Lorell BH. Selective changes in cardiac gene expression during compensated hypertrophy and the transition to cardiac decompensation in rats with chronic aortic banding. Circ Res. 1993;73:184-192.
26. Fazio S, Cittadini A, Sabatini D, Merola B, Colao AM, Biondi B, Lombardi G, Saccà L. Evidence for biventricular involvement in acromegaly: a Doppler echocardiographic study. Eur Heart J. 1993:14:26-33.
27. 2+ sensitivity in intact versus skinned rat ventricular muscle. Circ Res. 1994;74:408-415.
28. Duerr RL, Huang S, Miraliakbar HR, Ross C, Chien KR, Ross J Jr. Insulin-like growth factor-1 enhances ventricular hypertrophy and function during the onset of experimental cardiac failure. J Clin Invest. 1995;95:619-621.
29. Saccà L, Cittadini A, Fazio S. Growth hormone and the heart. Endocr Rev. 1994;15:555-573.
30. 2+ as an inotropic mechanism. Circulation. 1986;73(suppl III): III-85.
31. Schunkert H, Jackson B, Tang SS, Schoen FJ, Smits JFM, Apstein CS, Lorell BH. Distribution and functional significance of cardiac angiotensin converting enzyme in hypertrophied rat hearts. Circulation. 1993;87:1328-1339.
32. Gwathmey JK, Hajjar RJ. Intracellular calcium related to force development in twitch contraction of mammalian myocardium. Cell Calcium. 1990;11;531-538.
33. Wilson DM. Clinical actions of growth hormone. Endocrinol Metab Clin North Am. 1992;21:519-537.
34. Neely EK, Rosenfeld RG. Use and abuse of human growth hormone. Annu Rev Med. 1994;45:407-420.
35. Bondy CA, Underwood LE, Clemmons DR, Guler HP, Bach MA, Skarulis M. Clinical uses of insulin-like growth factor I. Ann Intern Med. 1994;120:593-601.